Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
US |
|
Christian Dior SE
PAR:CDI
|
FR |
|
Chocoladefabriken Lindt & Spruengli AG
SIX:LISN
|
CH |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
KR |
|
Schibsted ASA
OSE:SCHA
|
NO |
|
Nestle SA
SIX:NESN
|
CH |
|
Synopsys Inc
NASDAQ:SNPS
|
US |
|
Cadence Design Systems Inc
NASDAQ:CDNS
|
US |
|
NVIDIA Corp
NASDAQ:NVDA
|
US |
Intrinsic Value
The intrinsic value for
Regeneron Pharmaceuticals Inc (REGN) under the Base Case is hidden
USD.
Compared with the current market price of 702.27 USD, the stock appears hidden
.
REGN looks undervalued. But is it really? Some stocks live permanently below intrinsic value; one glance at Historical Valuation reveals if REGN is one of them.
Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Regeneron Pharmaceuticals Inc.
Fundamental Analysis
Revenue & Expenses Breakdown
Regeneron Pharmaceuticals Inc
Earnings Waterfall
Regeneron Pharmaceuticals Inc
The intrinsic value for
Regeneron Pharmaceuticals Inc (REGN) under the Base Case is hidden USD.
Compared with the current market price of 702.27 USD, the stock appears hidden.